Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: A randomized pilot trial

Carregando...
Imagem de Miniatura
Citações na Scopus
69
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
MOSBY-ELSEVIER
Citação
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, v.148, n.4, p.1647-1655, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: Acute acquired hypofibrinogenemia in children undergoing cardiac surgery is a major concern because it often results in perioperative bleeding and high rates of allogeneic blood transfusion. Fibrinogen concentrate has been proposed as an alternative to cryoprecipitate (the gold standard therapy), with minimal infectious and immunologic risks. Our objective was to investigate the efficacy and safety of fibrinogen concentrate in children undergoing cardiac surgery. Methods: In this randomized pilot study, patients were allocated to receive fibrinogen concentrate (60 mg/kg) or cryoprecipitate (10 mL/kg) if bleeding was associated with fibrinogen levels <1 g/dL after cardiopulmonary bypass weaning. The primary outcome was postoperative blood losses during the 48 hours after surgery. Results: A total of 63 patients were included in the study, 30 in the fibrinogen concentrate group and 33 in the cryoprecipitate group. The median 48-hour blood loss was not significantly different between the 2 groups (320 mL [interquartile range, 157-750] vs 410 mL [interquartile range, 215-510], respectively; P = .672). After treatment, plasma fibrinogen concentration increased similarly following administration of both products. There were no differences in allogeneic blood transfusion after intervention treatment. Conclusions: A large trial comparing fibrinogen concentrate and cryoprecipitate in the management of children with acute acquired hypofibrinogenemia during heart surgery is feasible. The preliminary results of our study showed that the use of fibrinogen concentrate was as efficient and safe as cryoprecipitate in the management of bleeding children undergoing cardiac surgery.
Palavras-chave
Referências
  1. Bennett-Guerrero E, 2010, JAMA-J AM MED ASSOC, V304, P1568, DOI 10.1001/jama.2010.1406
  2. Cui YL, 2010, ARTIF ORGANS, V34, P955, DOI 10.1111/j.1525-1594.2010.01148.x
  3. Fenger-Eriksen C, 2008, BRIT J ANAESTH, V101, P769, DOI 10.1093/bja/aen270
  4. Fenger-Eriksen C, 2009, EXPERT OPIN BIOL TH, V9, P1325, DOI 10.1517/14712590903193051
  5. Fenger-Eriksen C, 2009, J THROMB HAEMOST, V7, P795, DOI 10.1111/j.1538-7836.2009.03331.x
  6. Franchini M, 2012, BLOOD TRANSFUS-ITALY, V10, P23, DOI 10.2450/2011.0015-11
  7. Fries D, 2010, ANASTH INTENSIV NOTF, V45, P552, DOI 10.1055/s-0030-1265746
  8. Groner A, 2007, HAEMATOLOGICA, V92, P846
  9. Haas T, 2008, ANESTH ANALG, V106, P725, DOI [10.1213/ane.0b013e318163fb26, 10.1213/ane.0b013e3618163fb26]
  10. Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446
  11. Karlsson M, 2009, THROMB HAEMOSTASIS, V102, P137, DOI 10.1160/TH08-09-0587
  12. Karlsson M, 2008, TRANSFUSION, V48, P2152, DOI 10.1111/j.1537-2995.2008.01827.x
  13. Kozek-Langenecker S, 2011, CRIT CARE, V15, DOI 10.1186/cc10488
  14. Larsen SH, 2005, EUR J CARDIO-THORAC, V28, P877, DOI 10.1016/j.ejcts.2005.09.008
  15. Levy JH, 2013, TRANSFUSION
  16. Mittermayr M, 2007, ANESTH ANALG, V105, P905, DOI 10.1213/ol.ane.000020481.18570.27
  17. Rahe-Meyer N, 2009, BRIT J ANAESTH, V102, P785, DOI 10.1093/bja/aep089
  18. Rahe-Meyer N, 2011, J THROMB HAEMOST, V9, P1, DOI 10.1111/j.1538-7836.2010.04099.x
  19. Rahe-Meyer N, 2009, J THORAC CARDIOV SUR, V138, P694, DOI 10.1016/j.jtcvs.2008.11.065
  20. Rahe-Meyer N, 2013, ANESTHESIOLOGY, V118, P40, DOI 10.1097/ALN.0b013e3182715d4d
  21. Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943
  22. Solomon C, 2010, BRIT J ANAESTH, V104, P555, DOI 10.1093/bja/aeq058
  23. Sorensen B, 2010, BRIT J HAEMATOL, V149, P834, DOI 10.1111/j.1365-2141.2010.08208.x
  24. Stainsby D, 2006, BRIT J HAEMATOL, V135, P634
  25. Stanworth SJ, 2007, HEMATOL-AM SOC HEMAT, V2007, P179, DOI 10.1182/asheducation-2007.1.179
  26. Theodoulou A, 2012, TRANSFUS APHER SCI, V46, P159, DOI 10.1016/j.transci.2011.11.005
  27. Warmuth M, 2012, ACTA ANAESTH SCAND, V56, P539, DOI 10.1111/j.1399-6576.2011.02586.x
  28. Weber CF, 2012, ANESTHESIOLOGY, V117, P531, DOI 10.1097/ALN.0b013e318264c644